Asahi Kasei Pharma Eyes Global Expansion Of Diagnostics Business
This article was originally published in PharmAsia News
Executive Summary
Japan's Asahi Kasei Pharma plans an expansion of its diagnostics business by developing new products and selling its blood-sugar reagents in India and the U.S.